Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;61(4):1650-1661.
doi: 10.1002/jmri.29625. Epub 2024 Oct 3.

Early Detection of Myocardial Involvement in Thalassemia Intermedia Patients: Multiparametric Mapping by Magnetic Resonance Imaging

Antonella Meloni  1   2 , Laura Pistoia  2   3 , Davide Garamella  4 , Alessandro Parlato  4 , Vincenzo Positano  1   2 , Paolo Ricchi  5 , Tommaso Casini  6 , Emanuela De Marco  7 , Elisabetta Corigliano  8 , Zelia Borsellino  9 , Domenico Visceglie  10 , Raffaele De Caterina  4 , Alessia Pepe  11 , Filippo Cademartiri  2
Affiliations

Early Detection of Myocardial Involvement in Thalassemia Intermedia Patients: Multiparametric Mapping by Magnetic Resonance Imaging

Antonella Meloni et al. J Magn Reson Imaging. 2025 Apr.

Abstract

Background: No study has assessed myocardial T1 and T2 values in patients with beta-thalassemia intermedia (β-TI).

Purpose: To assess the prevalence of myocardial involvement in β-TI patients by T2* relaxometry and native T1 and T2 mapping and to determine the correlation of myocardial relaxation times with demographic and clinical parameters.

Study type: Prospective matched-cohort study.

Subjects: 42 β-TI patients (27 females, 39.65 ± 12.32 years), enrolled in the Extension-Myocardial Iron Overload in Thalassaemia Network, and 42 age- and sex-matched healthy volunteers (27 females, 40.01 ± 11.36 years) and thalassemia major (TM) patients (27 females, 39.27 ± 11.57 years).

Field strength/sequence: 1.5 T/multi-echo gradient echo, modified Look-Locker inversion recovery, multi-echo fast-spin-echo, cine balanced steady-state-free precession, and late gadolinium enhancement (LGE) sequences.

Assessment: Hepatic, pancreatic, and left ventricular (LV) T2* values, LV native T1 and T2 values, biventricular ejection fractions and volumes, and presence and extent of replacement myocardial fibrosis.

Statistical tests: Comparisons between two groups were performed with two-sample t tests, Wilcoxon's signed rank tests, or χ2 testing. Correlation analysis was performed using Pearson's or Spearman's test. P < 0.05 was considered statistically significant.

Results: β-TI patients had significantly higher LV T2 values than healthy subjects (56.84 ± 4.03 vs. 52.46 ± 2.50 msec, P < 0.0001) and significantly higher LV T1 values than TM patients (1018.32 ± 48.94 vs. 966.66 ± 66.47 msec, P < 0.0001). In β-TI, female gender was associated with significantly increased LV T1 (P = 0.041) and T2 values (P < 0.0001), while splenectomy and presence of regular transfusions were associated with significantly lower LV T1 values (P = 0.014 and P = 0.001, respectively). In β-TI patients, all LV relaxation times were significantly correlated with each other (T2*-T1: P = 0.003; T2*-T2: P = 0.003; T1-T2: P < 0.0001). Two patients with a reduced LV T2* also had a reduced LV T1, while only one had a reduced LV T2. Three patients had a reduced LV T1 but a normal LV T2*; 66.7% of the patients had an increased LV T2. All LV relaxation times were significantly correlated with pancreas T2* values (T2*: P = 0.033; T1: P < 0.0001; T2: P = 0.014). No LV relaxation time was associated (P > 0.05) with hepatic iron concentration, biventricular function parameters, or LGE presence.

Conclusion: The combined use of all three myocardial relaxation times has potential to improve sensitivity in the detection of early/subclinical myocardial involvement in β-Tl patients.

Level of evidence: 2 TECHNICAL EFFICACY: Stage 2.

Keywords: mapping; relaxation times; thalassemia intermedia.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Weatherall DJ. The thalassaemias. BMJ 1997;314(7095):1675‐1678.
    1. Taher AT, Musallam KM, El‐Beshlawy A, et al. Age‐related complications in treatment‐naive patients with thalassaemia intermedia. Br J Haematol 2010;150(4):486‐489.
    1. Ricchi P, Meloni A, Pistoia L, et al. Longitudinal follow‐up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: A cohort study. Br J Haematol 2020;191(1):107‐114.
    1. Akiki N, Hodroj MH, Bou‐Fakhredin R, Matli K, Taher AT. Cardiovascular complications in β‐thalassemia: Getting to the heart of it. Thalass Rep 2023;13(1):38‐50.
    1. Meloni A, Martini N, Positano V, et al. Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: A sensitive approach that correlates with cardiac complications. J Cardiovasc Magn Reson 2021;23(1):70.